Royce & Associates LP Purchases 10,000 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO)

Royce & Associates LP raised its position in Harvard Bioscience, Inc. (NASDAQ:HBIO) by 0.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,451,450 shares of the medical instruments supplier’s stock after acquiring an additional 10,000 shares during the quarter. Royce & Associates LP owned approximately 3.33% of Harvard Bioscience worth $3,904,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of HBIO. Allspring Global Investments Holdings LLC purchased a new position in Harvard Bioscience during the second quarter valued at $31,000. GSA Capital Partners LLP purchased a new position in shares of Harvard Bioscience during the 3rd quarter valued at about $30,000. Price T Rowe Associates Inc. MD purchased a new position in shares of Harvard Bioscience during the 1st quarter valued at about $54,000. SG Americas Securities LLC bought a new position in shares of Harvard Bioscience during the 3rd quarter valued at approximately $36,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in Harvard Bioscience in the 2nd quarter worth approximately $40,000. Institutional investors own 80.87% of the company’s stock.

Harvard Bioscience Stock Up 0.5 %

Shares of HBIO stock opened at $2.15 on Tuesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.06 and a quick ratio of 0.94. Harvard Bioscience, Inc. has a one year low of $2.12 and a one year high of $5.56. The company’s fifty day moving average price is $2.52 and its 200-day moving average price is $2.89. The company has a market capitalization of $93.78 million, a price-to-earnings ratio of -6.67 and a beta of 1.31.

Harvard Bioscience Profile

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.